Bharath Biotech has launched Phase-I trial (10 volunteers) of its intranasal vaccine BBV154 in Hyderabad, India. More trials are planned in Chennai, Nagpur and Patna.
A collage of noses from BING
https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/bharat-biotech-nasal-covid19-vaccine-phase-1-trials-hyderabad-1777780-2021-03-10
More here (March 12, 2021):
https://www.firstpost.com/tech/science/bharat-biotechs-intranasal-vaccine-for-covid-19-everything-we-know-so-far-about-bbv154-9408701.html
In addition to Bharath Biotech in India, three other companies/institutionss have been working on a nasal delviery system for the COVID_19 vaccine. They are,
The US company Altimmune is developing a nasal spary called AdCovid - 180 Volunteers
The company in UK, Codagenix is devleoping a nasal spray COVI-VAC in colloboration with the Serum Insitute in India--48 volunteers
China is working on its nasal vaccine, a colloboration betweeen Beijing Wantai Biological, Xiamen University and Hong Kong University-100 volunteers
No comments:
Post a Comment